Stocks edge lower as investors review earnings, await Fed

→ How to Make 100X on the AI Boom (From InvestorPlace) (Ad)

A woman walks past a bank's electronic board showing the Hong Kong share index at Hong Kong Stock Exchange Wednesday, July 28, 2021. Asian stock markets declined Wednesday after Wall Street pulled back from a record as investors awaited a Federal Reserve report for signs of when U.S. stimulus might be withdrawn. (AP Photo/Vincent Yu)

Stocks edged lower in morning trading on Wall Street Wednesday as investors reviewed the latest batch of quarterly earnings reports and wait for a policy update from the Federal Reserve.

Wall Street will be looking closely at the central bank’s statement to get a better sense of when it might start easing up on its support for the economy.

The S&P 500 fell 0.1% as of 9:58 a.m. Eastern time. The Dow Jones Industrial Average fell 46 points, or 0.1%, to 35,011 and the Nasdaq rose 0.4%.

The yield on the 10-year Treasury rose to 1.25% from 1.23% late Tuesday.

A slide from a few big technology stocks and a mix of consumer-oriented companies weighed on the market and offset gains from communications companies and banks. Google's parent company Alphabet was a standout, jumping 2.9% after reporting profit surge last quarter.

Analysts expect the Fed to taper bond purchases that have helped keep interest rates low through the pandemic. The big question for investors is the timing and pace of such a pullback. The market is also weighing concerns about the pace of the economic recovery, which could be stymied by the renewed spread of COVID-19.

There are also lingering concerns about whether inflation will continue to rise, depending on the economic recovery and supply chain problems that have made some goods more expensive.

Pfizer rose 1.7% after its profit and revenue surged on strong sales of its COVID-19 vaccine and other medicines. It also raised its sales and profit forecasts for the year. Boeing jumped 5.7% after the airplane maker reported a surprise quarterly profit, its first since 2019.

Solid earnings weren’t enough to lift stocks for other companies. McDonald’s fell 1.4%, despite reporting a surge in revenue and beating analysts’ forecasts as dining rooms reopened.

Markets made gains in Europe and were mostly lower in Asia.

→ The World’s Richest Man Blindsided by AI (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Pfizer right now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Boeing (BA)
2.6863 of 5 stars
$180.07+0.9%N/A-50.72Moderate Buy$222.41
Pfizer (PFE)
4.9968 of 5 stars
$28.30-0.5%5.94%-471.59Hold$35.86
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: